Current Location: Products in IDL Application

Products in IDL Application

The Group acquires all assets of overseas launched products related to the China market mainly through asset purchase, and applied for the Import Drug License (“IDL”) for products according to the requirements of the National Medical Products Administration (“NMPA”). Click on the product name for more details.